Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers

We are analyzing https://www.nature.com/articles/s41408-018-0130-3.

Title:
Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphoma | Blood Cancer Journal
Description:
MYD88 mutations are one of the most recurrent mutations in hematologic malignancies. However, recent mouse models suggest that MYD88L265P alone may not be sufficient to induce tumor formation. Interplay between MYD88L265P and other genetic events is further supported by the fact that TNFAIP3 (A20) inactivation often accompanies MYD88L265P. However, we are still lacking information about the consequence of MYD88L265P in combination with TNFAIP3 loss in human B cell lymphoma. Review of our genetic data on diffuse large B cell lymphoma (DLBCL) and Waldenstrom macroglobulinemia (WM), found that a large percentage of DLBCL and WM cases that have a MYD88 mutation also harbor a TNFAIP3 loss, 55% DLBCL and 28% of WM, respectively. To mimic this combination of genetic events, we used genomic editing technology to knock out TNFAIP3 in MYD88L265P non-Hodgkin’s lymphoma (NHL) cell lines. Loss of A20 expression resulted in increased NF-κB and p38 activity leading to upregulation of the NF-κB target genes BCL2 and MYC. Furthermore, we detected the increased production of IL-6 and CXCL10 which led to an upregulation of the JAK/STAT pathway. Overall, these results suggest that MYD88L265P signaling can be enhanced by a second genetic alteration in TNFAIP3 and highlights a potential opportunity for therapeutic targeting.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}


Display Ads {🎯}

$63,100 per month
Our analysis indicates Nature.com generates between $42,042 and $115,616 monthly online from display ads.

Keywords {🔍}

pubmed, cell, article, myd, google, scholar, tnfaip, cas, loss, lymphoma, dlbcl, expression, central, data, genetic, lines, bcell, cells, large, bcl, analysis, blood, diffuse, nfκb, mutations, mutation, patients, signaling, mydlp, myc, ibrutinib, usa, stat, shown, mwclako, hblako, nature, target, fig, cancer, activation, gene, cxcl, study, macroglobulinemia, upregulation, line, combination, mayo, survival,

Topics {✒️}

nature portfolio privacy policy health sciences research ubiquitin-editing enzyme a20 talen genome-editing technology advertising formalin-fixed paraffin-embedded tissue b-cell-specific conditional expression nature 470 nature 459 nature 483 nature research 2-tailed student t-test patient-derived xenograft models genomic editing technology reprints inducible ubiquitin-modifying enzyme genome editing activated b-cell subtype wilcoxon–mann–whitney test nf-κb target genes10 nf-κb target genes2 myd88 drive development inhibit b-cell receptor nf-κb target genes quantitative reverse transcriptase-pcr author information authors double-expressor lymphoma genome-wide analysis uncovers counteract myd88-driven proliferation 3h-thymidine incorporation levels b-cell receptor activation library preparation high-risk dlbcl keenan deregulated nf-κb activation real-time quantitative pcr quantitative real-time pcr increased baseline nf-κb nf-kb signaling pathways gene expression-based method nuclear factor-κb pathways permissions b-cell lymphoma hbl-1-a20ko cell line double expressing abc-dlbcl abc-dlbcl cell line bcl-2 family proteins author correspondence original author

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphoma
         description:MYD88 mutations are one of the most recurrent mutations in hematologic malignancies. However, recent mouse models suggest that MYD88L265P alone may not be sufficient to induce tumor formation. Interplay between MYD88L265P and other genetic events is further supported by the fact that TNFAIP3 (A20) inactivation often accompanies MYD88L265P. However, we are still lacking information about the consequence of MYD88L265P in combination with TNFAIP3 loss in human B cell lymphoma. Review of our genetic data on diffuse large B cell lymphoma (DLBCL) and Waldenstrom macroglobulinemia (WM), found that a large percentage of DLBCL and WM cases that have a MYD88 mutation also harbor a TNFAIP3 loss, 55% DLBCL and 28% of WM, respectively. To mimic this combination of genetic events, we used genomic editing technology to knock out TNFAIP3 in MYD88L265P non-Hodgkin’s lymphoma (NHL) cell lines. Loss of A20 expression resulted in increased NF-κB and p38 activity leading to upregulation of the NF-κB target genes BCL2 and MYC. Furthermore, we detected the increased production of IL-6 and CXCL10 which led to an upregulation of the JAK/STAT pathway. Overall, these results suggest that MYD88L265P signaling can be enhanced by a second genetic alteration in TNFAIP3 and highlights a potential opportunity for therapeutic targeting.
         datePublished:2018-10-09T00:00:00Z
         dateModified:2018-10-09T00:00:00Z
         pageStart:1
         pageEnd:11
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1038/s41408-018-0130-3
         keywords:
            B-cell lymphoma
            Biomedicine
            general
            Cancer Research
            Oncology
            Hematology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41408-018-0130-3/MediaObjects/41408_2018_130_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41408-018-0130-3/MediaObjects/41408_2018_130_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41408-018-0130-3/MediaObjects/41408_2018_130_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41408-018-0130-3/MediaObjects/41408_2018_130_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41408-018-0130-3/MediaObjects/41408_2018_130_Fig5_HTML.png
         isPartOf:
            name:Blood Cancer Journal
            issn:
               2044-5385
            volumeNumber:8
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Kerstin Wenzl
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Division of Hematology, Mayo Clinic, Rochester, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Michelle K. Manske
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Division of Hematology, Mayo Clinic, Rochester, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Vivekananda Sarangi
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Department of Health Sciences Research, Mayo Clinic, Rochester, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yan W. Asmann
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Department of Health Sciences Research, Mayo Clinic, Jacksonville, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Patricia T. Greipp
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Genomics Laboratory, Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hanna R. Schoon
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Division of Hematology, Mayo Clinic, Rochester, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Esteban Braggio
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Division of Hematology, Mayo Clinic, Phoenix, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Matthew J. Maurer
               url:http://orcid.org/0000-0002-1867-0526
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Department of Health Sciences Research, Mayo Clinic, Rochester, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Andrew L. Feldman
               url:http://orcid.org/0000-0001-5009-4808
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Thomas E. Witzig
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Division of Hematology, Mayo Clinic, Rochester, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Susan L. Slager
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Department of Health Sciences Research, Mayo Clinic, Rochester, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Stephen M. Ansell
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Division of Hematology, Mayo Clinic, Rochester, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:James R. Cerhan
               url:http://orcid.org/0000-0002-7482-178X
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Department of Health Sciences Research, Mayo Clinic, Rochester, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Anne J. Novak
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Division of Hematology, Mayo Clinic, Rochester, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphoma
      description:MYD88 mutations are one of the most recurrent mutations in hematologic malignancies. However, recent mouse models suggest that MYD88L265P alone may not be sufficient to induce tumor formation. Interplay between MYD88L265P and other genetic events is further supported by the fact that TNFAIP3 (A20) inactivation often accompanies MYD88L265P. However, we are still lacking information about the consequence of MYD88L265P in combination with TNFAIP3 loss in human B cell lymphoma. Review of our genetic data on diffuse large B cell lymphoma (DLBCL) and Waldenstrom macroglobulinemia (WM), found that a large percentage of DLBCL and WM cases that have a MYD88 mutation also harbor a TNFAIP3 loss, 55% DLBCL and 28% of WM, respectively. To mimic this combination of genetic events, we used genomic editing technology to knock out TNFAIP3 in MYD88L265P non-Hodgkin’s lymphoma (NHL) cell lines. Loss of A20 expression resulted in increased NF-κB and p38 activity leading to upregulation of the NF-κB target genes BCL2 and MYC. Furthermore, we detected the increased production of IL-6 and CXCL10 which led to an upregulation of the JAK/STAT pathway. Overall, these results suggest that MYD88L265P signaling can be enhanced by a second genetic alteration in TNFAIP3 and highlights a potential opportunity for therapeutic targeting.
      datePublished:2018-10-09T00:00:00Z
      dateModified:2018-10-09T00:00:00Z
      pageStart:1
      pageEnd:11
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1038/s41408-018-0130-3
      keywords:
         B-cell lymphoma
         Biomedicine
         general
         Cancer Research
         Oncology
         Hematology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41408-018-0130-3/MediaObjects/41408_2018_130_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41408-018-0130-3/MediaObjects/41408_2018_130_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41408-018-0130-3/MediaObjects/41408_2018_130_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41408-018-0130-3/MediaObjects/41408_2018_130_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41408-018-0130-3/MediaObjects/41408_2018_130_Fig5_HTML.png
      isPartOf:
         name:Blood Cancer Journal
         issn:
            2044-5385
         volumeNumber:8
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Kerstin Wenzl
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Division of Hematology, Mayo Clinic, Rochester, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Michelle K. Manske
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Division of Hematology, Mayo Clinic, Rochester, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Vivekananda Sarangi
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Department of Health Sciences Research, Mayo Clinic, Rochester, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yan W. Asmann
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Department of Health Sciences Research, Mayo Clinic, Jacksonville, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Patricia T. Greipp
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Genomics Laboratory, Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hanna R. Schoon
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Division of Hematology, Mayo Clinic, Rochester, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Esteban Braggio
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Division of Hematology, Mayo Clinic, Phoenix, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Matthew J. Maurer
            url:http://orcid.org/0000-0002-1867-0526
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Department of Health Sciences Research, Mayo Clinic, Rochester, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Andrew L. Feldman
            url:http://orcid.org/0000-0001-5009-4808
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Thomas E. Witzig
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Division of Hematology, Mayo Clinic, Rochester, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Susan L. Slager
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Department of Health Sciences Research, Mayo Clinic, Rochester, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stephen M. Ansell
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Division of Hematology, Mayo Clinic, Rochester, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:James R. Cerhan
            url:http://orcid.org/0000-0002-7482-178X
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Department of Health Sciences Research, Mayo Clinic, Rochester, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Anne J. Novak
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Division of Hematology, Mayo Clinic, Rochester, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Blood Cancer Journal
      issn:
         2044-5385
      volumeNumber:8
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Mayo Clinic
      address:
         name:Division of Hematology, Mayo Clinic, Rochester, USA
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Division of Hematology, Mayo Clinic, Rochester, USA
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Department of Health Sciences Research, Mayo Clinic, Rochester, USA
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Department of Health Sciences Research, Mayo Clinic, Jacksonville, USA
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Genomics Laboratory, Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Division of Hematology, Mayo Clinic, Rochester, USA
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Division of Hematology, Mayo Clinic, Phoenix, USA
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Department of Health Sciences Research, Mayo Clinic, Rochester, USA
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Division of Hematology, Mayo Clinic, Rochester, USA
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Department of Health Sciences Research, Mayo Clinic, Rochester, USA
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Division of Hematology, Mayo Clinic, Rochester, USA
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Department of Health Sciences Research, Mayo Clinic, Rochester, USA
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Division of Hematology, Mayo Clinic, Rochester, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Kerstin Wenzl
      affiliation:
            name:Mayo Clinic
            address:
               name:Division of Hematology, Mayo Clinic, Rochester, USA
               type:PostalAddress
            type:Organization
      name:Michelle K. Manske
      affiliation:
            name:Mayo Clinic
            address:
               name:Division of Hematology, Mayo Clinic, Rochester, USA
               type:PostalAddress
            type:Organization
      name:Vivekananda Sarangi
      affiliation:
            name:Mayo Clinic
            address:
               name:Department of Health Sciences Research, Mayo Clinic, Rochester, USA
               type:PostalAddress
            type:Organization
      name:Yan W. Asmann
      affiliation:
            name:Mayo Clinic
            address:
               name:Department of Health Sciences Research, Mayo Clinic, Jacksonville, USA
               type:PostalAddress
            type:Organization
      name:Patricia T. Greipp
      affiliation:
            name:Mayo Clinic
            address:
               name:Genomics Laboratory, Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA
               type:PostalAddress
            type:Organization
      name:Hanna R. Schoon
      affiliation:
            name:Mayo Clinic
            address:
               name:Division of Hematology, Mayo Clinic, Rochester, USA
               type:PostalAddress
            type:Organization
      name:Esteban Braggio
      affiliation:
            name:Mayo Clinic
            address:
               name:Division of Hematology, Mayo Clinic, Phoenix, USA
               type:PostalAddress
            type:Organization
      name:Matthew J. Maurer
      url:http://orcid.org/0000-0002-1867-0526
      affiliation:
            name:Mayo Clinic
            address:
               name:Department of Health Sciences Research, Mayo Clinic, Rochester, USA
               type:PostalAddress
            type:Organization
      name:Andrew L. Feldman
      url:http://orcid.org/0000-0001-5009-4808
      affiliation:
            name:Mayo Clinic
            address:
               name:Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA
               type:PostalAddress
            type:Organization
      name:Thomas E. Witzig
      affiliation:
            name:Mayo Clinic
            address:
               name:Division of Hematology, Mayo Clinic, Rochester, USA
               type:PostalAddress
            type:Organization
      name:Susan L. Slager
      affiliation:
            name:Mayo Clinic
            address:
               name:Department of Health Sciences Research, Mayo Clinic, Rochester, USA
               type:PostalAddress
            type:Organization
      name:Stephen M. Ansell
      affiliation:
            name:Mayo Clinic
            address:
               name:Division of Hematology, Mayo Clinic, Rochester, USA
               type:PostalAddress
            type:Organization
      name:James R. Cerhan
      url:http://orcid.org/0000-0002-7482-178X
      affiliation:
            name:Mayo Clinic
            address:
               name:Department of Health Sciences Research, Mayo Clinic, Rochester, USA
               type:PostalAddress
            type:Organization
      name:Anne J. Novak
      affiliation:
            name:Mayo Clinic
            address:
               name:Division of Hematology, Mayo Clinic, Rochester, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Division of Hematology, Mayo Clinic, Rochester, USA
      name:Division of Hematology, Mayo Clinic, Rochester, USA
      name:Department of Health Sciences Research, Mayo Clinic, Rochester, USA
      name:Department of Health Sciences Research, Mayo Clinic, Jacksonville, USA
      name:Genomics Laboratory, Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA
      name:Division of Hematology, Mayo Clinic, Rochester, USA
      name:Division of Hematology, Mayo Clinic, Phoenix, USA
      name:Department of Health Sciences Research, Mayo Clinic, Rochester, USA
      name:Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA
      name:Division of Hematology, Mayo Clinic, Rochester, USA
      name:Department of Health Sciences Research, Mayo Clinic, Rochester, USA
      name:Division of Hematology, Mayo Clinic, Rochester, USA
      name:Department of Health Sciences Research, Mayo Clinic, Rochester, USA
      name:Division of Hematology, Mayo Clinic, Rochester, USA

Social Networks {👍}(1)

External Links {🔗}(283)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Hammer.js
  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk
4.65s.